{
    "title": "Valeant picks up AstraZeneca psoriasis drug after Amgen exit",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-3217978/Valeant-picks-AstraZeneca-psoriasis-drug-Amgen-exit.html",
    "date": "2015-09-01",
    "keywords": [
        "psoriasis",
        "drug",
        "milestone",
        "amgen",
        "gmt",
        "september",
        "inc",
        "brodalumab",
        "quarter",
        "valeant",
        "exit",
        "email",
        "latestage",
        "mayamgen",
        "project",
        "medicine",
        "shadow",
        "prospectsvaleant",
        "tuesday",
        "payment",
        "prelaunch",
        "europe",
        "arrangement",
        "japan",
        "kyowa",
        "hakko",
        "kirin",
        "cobrodalumab",
        "class",
        "il17",
        "pathway",
        "role",
        "autoimmune",
        "disease",
        "growth",
        "cycle",
        "skin",
        "deal",
        "income",
        "externalisation",
        "revenue",
        "reporting",
        "ben",
        "hirschler",
        "london",
        "kurane",
        "bengaluru",
        "editing",
        "gopakumar",
        "david",
        "clarke"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}